Publications by authors named "David Loh"

Article Synopsis
  • VYC-25L is a hyaluronic acid filler approved in 2019 for facial volumizing, lifting, and contouring, offering a long-lasting effect of at least 24 months.
  • Experienced doctors highlight its unique properties, including high lift capacity, moldability, and tissue integration, which enhance its use in non-surgical facial aesthetics.
  • Proper technique and cautious application are essential for maximizing patient benefits, including starting with the chin and jawline and following best practice principles to ensure safety and effectiveness.
View Article and Find Full Text PDF

Unlabelled: Botulinum neurotoxin A (BoNT-A) injection is the most widely performed aesthetic procedure and a first-line therapeutic option for various medical conditions. The potential for BoNT-A immunoresistance and secondary nonresponse related to neutralizing antibody (NAb) formation warrants attention as the range of BoNT-A aesthetic applications continues to expand.

Methods: An international multidisciplinary panel reviewed published evidence on BoNT-A immunoresistance in aesthetic and therapeutic applications and discussed best practices integrating clinical, ethical, and aesthetic considerations.

View Article and Find Full Text PDF

Background: The use of hyaluronic acid (HA) fillers for medical aesthetic purposes is increasing worldwide. Nonetheless, adverse events do occur because of patient-specific issues, injection technique, or product factors. It would be mandatory to consider cultural and anatomical features of Asians in preventing and managing the complications of HA injections.

View Article and Find Full Text PDF

Introduction: This study describes the physician experience relating to the effectiveness of incobotulinumtoxinA and patient satisfaction with its use for the treatment of glabellar frown lines (GFLs).

Methods: A total of 17 patients from six dermatological clinics, aged > 18 years and with mild to very severe GFLs at maximum frown, were included. Patients were excluded if they had treatment with resorbable fillers and botulinum toxins in the preceding six months, or non-resorbable fillers or surgery in the treatment area.

View Article and Find Full Text PDF

The workforce of any health care organization is vital to its continued survival, but a highly competent and committed workforce is vital to its success. The evidence is clear: employees influence not only the financial performance of the organization, but also the safety and quality of the clinical care provided to patients. Health care organizations must understand these important linkages and have in place corporate strategies to manage workforce issues with a systems focus that ensures excellent leadership and operational processes, a healthy culture, and optimum patient outcomes.

View Article and Find Full Text PDF